Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares BRCA reversion mutations, Rucaparib, Tumour (somatic or germline) BRCA1/2 mutation and HRR gene alterations, Germline BRCA1/2 pathogenic variant (gBRCAm) and the tag subtype-page.
Shares Saruparib, BRCA reversion mutations, Rucaparib, Tumour (somatic or germline) BRCA1/2 mutation and HRR gene alterations and the tag subtype-page.
Shares Chromoplexy, TNM staging for prostate cancer, and what changed in the 9th edition, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Biochemical recurrence of prostate cancer and the tag subtype-page.
Shares Prostate Cancer UK, PSA kinetics: PSA doubling time and PSA density, TNM staging for prostate cancer, and what changed in the 9th edition, Biochemical recurrence of prostate cancer and the tag subtype-page.
Shares PTEN loss, Talazoparib, Germline BRCA mutation (gBRCA), Olaparib and the tag subtype-page.
Shares TNM staging for prostate cancer, and what changed in the 9th edition, Biochemical recurrence of prostate cancer, Prostate cancer roadmap: from Huggins and the discovery that a cancer can depend on a hormone, through the PSA epidemic and what it cost, the androgen receptor drugs, the DNA repair subset and PSMA, to a 2032 registry watch, SBRT / SABR (stereotactic radiotherapy) and the tag subtype-page.
Shares Saruparib, Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Olaparib, Pembrolizumab and the tag subtype-page.
Shares PTEN alteration (sequencing) and PTEN loss (IHC), Germline BRCA1/2 pathogenic variant (gBRCAm), Talazoparib, Germline BRCA mutation (gBRCA) and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-25. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.